Terms: = Thyroid cancer AND TRA
29 results:
1. Pharmacokinetics/Pharmacodynamics of Dabrafenib and trametinib for Redifferentiation and Treatment of Radioactive Iodine-Resistant Mutated Advanced Differentiated thyroid cancer.
Balakirouchenane D; Seban R; Groussin L; Puszkiel A; Cottereau AS; Clerc J; Vidal M; Goldwasser F; Arrondeau J; Blanchet B; Huillard O
Thyroid; 2023 Nov; 33(11):1327-1338. PubMed ID: 37725566
[No Abstract] [Full Text] [Related]
2. Operator radiation dose during trans-hepatic arterial chemoembolization: different patients' positions via transradial or transfemoral access.
Jiang H; Chen Y; Liao H; Gu Y; Meng X; Dong W
Diagn Interv Radiol; 2022 Jul; 28(4):376-382. PubMed ID: 35950283
[TBL] [Abstract] [Full Text] [Related]
3. tracheal and Cricotracheal Resection With End-to-End Anastomosis for Locally Advanced thyroid cancer: A Systematic Review of the Literature on 656 Patients.
Piazza C; Lancini D; Tomasoni M; D'Cruz A; Hartl DM; Kowalski LP; Randolph GW; Rinaldo A; Shah JP; Shaha AR; Simo R; Vander Poorten V; Zafereo M; Ferlito A
Front Endocrinol (Lausanne); 2021; 12():779999. PubMed ID: 34858348
[TBL] [Abstract] [Full Text] [Related]
4. De-escalated Therapy Omitting Anthracyclines for Stage I HER2-positive Breast cancer: A Retrospective Observational Study.
Nakamoto S; Ikeda M; Kubo S; Yamamoto M; Yamashita T
In Vivo; 2020; 34(6):3713-3718. PubMed ID: 33144488
[TBL] [Abstract] [Full Text] [Related]
5. Multicentric study applying the european laryngological society classification of benign laryngotracheal stenosis in adults treated by tracheal or cricotracheal resection and anastomosis.
Fiz I; Monnier P; Koelmel JC; Di Dio D; Fiz F; Missale F; Piazza C; Peretti G; Sittel C
Laryngoscope; 2020 Jul; 130(7):1640-1645. PubMed ID: 31508817
[TBL] [Abstract] [Full Text] [Related]
6. Phosphorylated HER3 and FITC-labeled trastuzumab immunohistochemistry in patients with HER2-positive breast cancer treated with adjuvant trastuzumab.
Kanomata N; Kurebayashi J; Moriya T
Med Mol Morphol; 2019 Jun; 52(2):106-113. PubMed ID: 30317526
[TBL] [Abstract] [Full Text] [Related]
7. thyroid hormone receptor alpha (tra) tissue expression in ductal invasive breast cancer: A study combining quantitative immunohistochemistry with digital slide image analysis.
Charalampoudis P; Agrogiannis G; Kontzoglou K; Kouraklis G; Sotiropoulos GC
Eur J Surg Oncol; 2017 Aug; 43(8):1428-1432. PubMed ID: 28583788
[TBL] [Abstract] [Full Text] [Related]
8. Effectiveness of Reduced Radioiodine Activity for thyroid Remnant Ablation after Total thyroidectomy in Patients with Low to Intermediate Risk Differentiated thyroid Carcinoma.
Todica A; Haidvogl S; Fendler WP; Ilhan H; Rominger A; Haug AR; Bartenstein P; Lehner S
Nuklearmedizin; 2017; 56(6):211-218. PubMed ID: 29533416
[TBL] [Abstract] [Full Text] [Related]
9. thyroid Patient Salivary Radioiodine transit and Dysfunction Assessment Using Chewing Gums.
Okkalides D
Cancer Biother Radiopharm; 2016 Nov; 31(9):330-341. PubMed ID: 27831763
[TBL] [Abstract] [Full Text] [Related]
10. The Result of Multiple I-131 Treatments on the Effective Half-Life of Retained Radioactivity in Patients Ablated for Differentiated thyroid cancer: Possible Evidence for thyroid Remnant Function Impairment.
Okkalides D
Cancer Biother Radiopharm; 2016 Mar; 31(2):58-64. PubMed ID: 26986816
[TBL] [Abstract] [Full Text] [Related]
11. thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy in a real-life scenario.
Campennì A; Giovanella L; Pignata SA; Violi MA; Siracusa M; Alibrandi A; Moleti M; Amato E; Ruggeri RM; Vermiglio F; Baldari S
Nucl Med Commun; 2015 Nov; 36(11):1100-6. PubMed ID: 26302462
[TBL] [Abstract] [Full Text] [Related]
12. tracheal and Crico-tracheal Resection and Anastomosis for Malignancies Involving the thyroid Gland and the Airway.
Piazza C; Del Bon F; Barbieri D; Grazioli P; Paderno A; Perotti P; Lombardi D; Peretti G; Nicolai P
Ann Otol Rhinol Laryngol; 2016 Feb; 125(2):97-104. PubMed ID: 26296930
[TBL] [Abstract] [Full Text] [Related]
13. microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.
Lakshmanan A; Wojcicka A; Kotlarek M; Zhang X; Jazdzewski K; Jhiang SM
Endocr Relat Cancer; 2015 Feb; 22(1):11-21. PubMed ID: 25404690
[TBL] [Abstract] [Full Text] [Related]
14. Sorafenib sensitizes solid tumors to Apo2L/traIL and Apo2L/traIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis.
Abdulghani J; Allen JE; Dicker DT; Liu YY; Goldenberg D; Smith CD; Humphreys R; El-Deiry WS
PLoS One; 2013; 8(9):e75414. PubMed ID: 24086526
[TBL] [Abstract] [Full Text] [Related]
15. Long-term outcomes following low-dose radioiodide ablation for differentiated thyroid cancer.
Welsh L; Powell C; Pratt B; Harrington K; Nutting C; Harmer C; Newbold K
J Clin Endocrinol Metab; 2013 May; 98(5):1819-25. PubMed ID: 23493434
[TBL] [Abstract] [Full Text] [Related]
16. Regulation of sodium iodide symporter gene expression by Rac1/p38β mitogen-activated protein kinase signaling pathway in MCF-7 breast cancer cells.
Kogai T; Liu YY; Mody K; Shamsian DV; Brent GA
J Biol Chem; 2012 Jan; 287(5):3292-300. PubMed ID: 22157753
[TBL] [Abstract] [Full Text] [Related]
17. Molecular characterization of a novel chromosomal translocation t(12;14)(q23;q11.2) in T-lymphoblastic lymphoma between the T-cell receptor delta-deleting elements (TRDREC and traJ61) and the hypothetical gene C12orf42.
Przybylski GK; Dittmann K; Grabarczyk P; Dölken G; Gesk S; Harder L; Landmann E; Siebert R; Schmidt CA
Eur J Haematol; 2010 Nov; 85(5):452-6. PubMed ID: 20659153
[TBL] [Abstract] [Full Text] [Related]
18. Protocol for thyroid remnant ablation after recombinant TSH in thyroid carcinoma.
Pitoia F; El Tamer E; Salvai ME; Niepomniszcze H
Medicina (B Aires); 2009; 69(1 Pt 2):148-52. PubMed ID: 19414296
[TBL] [Abstract] [Full Text] [Related]
19. Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells.
Ohashi E; Kogai T; Kagechika H; Brent GA
Cancer Res; 2009 Apr; 69(8):3443-50. PubMed ID: 19351850
[TBL] [Abstract] [Full Text] [Related]
20. Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I/phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways.
Kogai T; Ohashi E; Jacobs MS; Sajid-Crockett S; Fisher ML; Kanamoto Y; Brent GA
J Clin Endocrinol Metab; 2008 May; 93(5):1884-92. PubMed ID: 18319322
[TBL] [Abstract] [Full Text] [Related]
[Next]
